Navigation Links
Controlling movements with light
Date:7/20/2011

Unlike conventional methods, with the so-called optogenetics, the researchers are able to target one cell type. "We are now going to use this method to find out exactly what goes wrong in the nerve cells in movement disorders such as ataxias", said Prof. Dr. Stefan Herlitze (RUB Department for Biology and Biotechnology). The researchers report in the Journal of Biological Chemistry. The Bochum team examined a specific signalling pathway that is controlled by a so-called G-protein-coupled receptor. This pathway is important for the modulation of activity in complex neuronal networks. Disturbances of the function can, for example, have an effect on emotional and motor behaviours. "We know that the activity pattern of the Purkinje cells in the cerebellum is crucial for the coordination of movements", Herlitze explained. "It is unclear, however, what contribution is made by the individual receptors." In conventional studies, researchers use drugs that inhibit or stimulate specific proteins in nerve cells to investigate the contribution of these proteins to the activity of the cells. However, Herlitze's team was interested in a protein (G-protein-coupled receptor) which occurs in various cell types. Had the researchers administered a drug, they would not only have deactivated the receptor in the Purkinje cells, but in all cell types in which it occurs. The drug method therefore makes it impossible to observe the contribution of the receptor in the Purkinje cells in isolation.

Optogenetics: replacing drugs with light

To avoid this problem, Herlitze's team replaced the drugs with proteins that are activated by light. Using genetic methods, the researchers integrated rhodopsin, the light-sensitive protein of the eye, into the Purkinje cells of mice. They also implanted a laser probe in the cerebellum, with which they illuminated the rhodopsin. The light-activated rhodopsin then activated the G-protein-coupled receptor in the Purkinje cells, while the same receptors in other cell types remained inactive. The RUB Department of General Zoology and Neurobiology has been instrumental in establishing this method worldwide.

Investigated receptor is crucial for movement control

The researchers found that activation of the G-protein-coupled receptor changed the activity pattern of the Purkinje cells. Herlitze's team had to expose the rhodopsin to light for several seconds to achieve these effects. A twenty to thirty percent reduction in cell activity was sufficient to induce visible motor deficits in the behaviour of the mice, such as impaired balance or coordination problems. "We were able to demonstrate for the first time that the modulation of a specific G-protein-coupled receptor in the Purkinje cells is of crucial importance for the control and coordination of movement", summed up Herlitze.


'/>"/>

Contact: Stefan Herlitze
stefan.herlitze@rub.de
49-234-322-4363
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Starch-controlling gene fuels more protein in soybean plants
2. Toward controlling fungus that caused Irish potato famine
3. Scripps Research scientist uncovers switch controlling protein production
4. Scientists discover new mechanism for controlling blood sugar level
5. Artificially controlling water condensation leads to room-temperature ice
6. Balanced ecosystems seen in organic ag better at controlling pests
7. Production of biofuels could benefit by controlling the types of cells that develop in plants
8. More than 1: Long-reigning microbe controlling ocean nitrogen shares the throne
9. UNC study pinpoints gene controlling number of brain cells
10. Key protein regulating inflammation may prove relevant to controlling sepsis
11. Photoselective film proves effective for controlling height in potted gardenia plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... -- According to a new market research report "Consumer IAM ... and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global ... grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
(Date:10/9/2017)... Phoenix, Arizona (PRWEB) , ... October 09, 2017 ... ... of Kindred, a four-tiered line of medical marijuana products targeting the needs of ... production and packaging of Kindred takes place in Phoenix, Arizona. , As operators ...
(Date:10/7/2017)... WA (PRWEB) , ... October ... ... industry leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution ... ProxiMeta Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome ...
(Date:10/6/2017)... ... October 06, 2017 , ... On ... and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). The ... The event is free and open to the public, but registration is required. ...
Breaking Biology Technology: